Seeking Alpha


Send Message
View as an RSS Feed
Latest  |  Highest rated
  • As Pfizer Eyes It, Celgene Calls Cellceutix [View article]
    Quick note; your mention of the U of Barcelona I believe should be the U of Bologna in Italy as they are poised to begin a Kevetrin/Cytarabine trial as soon as the Dana-Farber results proceed a bit further and stronger doses have been deemed safe.

    CTIX certainly does possess the potential for the lofty numbers of which you speak.

    Disclaimer: I am a current CTIX investor.
    May 31, 2013. 12:44 PM | 1 Like Like |Link to Comment
  • CLSN Daily Chart Ringing The Bell? [View instapost]
    Your info is always spot on and deals in quantifiable facts rather than bias and guesstimating.
    Jan 30, 2013. 03:39 AM | Likes Like |Link to Comment
1 Like